Pacira | PCRX - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Assertio Holdings USD 166.78M 34.25M 2025-09
Astellas Pharma JPY 1.32T 873M 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Cara Therapeutics USD 11.04M 362K 2025-09
Coherus Biosciences USD 140.39M 231.91M 2025-12
Heron Therapeutics USD 96.1M 6.39M 2025-12
Ironwood Pharmaceuticals USD 242.5M 9.98M 2025-09
J&J USD 54.13B 3.26B 2025-12
Ligand Pharmaceuticals USD 37.45M 6.91M 2025-12
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Novo Nordisk DKK 215.66B 18.7B 2025-12
Omeros USD 85.5M 2.28M 2025-06
Pacira USD 120.59M 13.51M 2025-12
Perrigo USD 1.01B 132.4M 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Supernus Pharmaceuticals USD 338.17M 7.54M 2025-12
Teva Pharmaceutical Industries USD 13.46B 1.96B 2025-12
Xeris Pharmaceuticals USD 109.57M 6.63M 2025-12
Xoma USD 28.3M 6.81M 2025-09
Zoetis USD 2.24B 428M 2025-12